IP Library Granted Patent US 8,486,410
Granted Patent B2
US 8,486,410 · App. 11/741,447 · Granted Jul 16, 2013

RLIP76 liposomes for protection against irradiation

Inventors: Sanjay Awasthi (Arlington, TX); Sharad S. Singhal (Arlington, TX)
Assignee: Board of Regents, The University of Texas System
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,486,410
App. No.
11/741,447
Granted
Jul 16, 2013
Kind
B2
Abstract

Methods of preparing a proteoliposome comprise the step of contacting a liposome with an effective portion of RalBP1 to create a proteoliposome. RalBP1 is effective for the protection and treatment of mammals and the environment against the accumulation of toxic compounds and prevents accumulation of one or more toxic compounds, reduces the concentration of toxic compounds, and protects against further contamination with one or more toxic compounds.

Claims (9)

1. A method of protecting a mammal against damaging radiation, comprising administering an effective amount of RLIP76 to said mammal after, or prior to and after the damaging radiation, wherein said RLIP76 is comprised within a liposome.

2. The method of claim 1 , wherein said RLIP76 is administered to said mammal 3 days prior to, 3 days after, and 5 days after said damaging radiation.

3. The method of claim 1 , wherein said radiation is electromagnetic, ionizing, thermal, or laser radiation.

4. The method of claim 3 , wherein said radiation is electromagnetic radiation.

5. The method of claim 1 , wherein said radiation is X-radiation, γ-radiation, UV radiation, or nuclear radiation.

6. The method of claim 5 , wherein said radiation is X-radiation.

7. A method of reducing the effects of ionizing radiation on one or more mammalian cells in a mammalian organism, comprising contacting said mammalian cells or organism with a liposome comprising RLIP76 or an effective portion thereof after, or prior to and after exposure to the ionizing radiation.

8. The method of claim 7 , wherein said ionizing radiation is electromagnetic radiation, X-radiation, γ-radiation, or UV radiation.

9. The method of claim 7 , wherein said organism is contacted with a liposome comprising RLIP76 or an effective portion thereof 3 days prior to, 3 days after, and 5 days after said ionizing radiation.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 23, 2013
From: AWASTHI, SANJAY; SINGHAI, SHARAD S.
To: BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM
Reel/Frame 030263/0784 →
CONFIRMATORY LICENSE Recorded Oct 26, 2011
From: THE UNIVERSITY OF TEXAS AT ARLINGTON
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 027124/0765 →
Continuity (3)
Division 10713578 · Nov 13, 2003
Provisional Application 60425814 · Nov 13, 2002
Related Publication 20080279919A1 · Nov 13, 2008